Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.

about

Metabolic Remodeling in Diabetic Cardiomyopathy.Novel avenues for treating diabetic nephropathy: new investigational drugs.Cellular death, reactive oxygen species (ROS) and diabetic complications.Identification of Protein Kinase C Isoforms Involved in Type 1 Diabetic Encephalopathy in Mice.

P2860

Q33623469-1D9683AC-C942-4E34-8F70-2FA445336C0C Q39170387-703C4F92-537B-4F12-A249-7B3A1DB892D6 Q49679592-ABF5CF42-3944-42E4-AA9A-8F542D23DC68 Q54111057-D19483A2-D29A-477A-B019-37FA1383B403

P2860

Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.

Item

http://www.wikidata.org/entity/Q40053242

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ruboxistaurin attenuates diabe ...... TGF-β1/Smad and GRAP pathways.

@en

type

Item

label

Ruboxistaurin attenuates diabe ...... TGF-β1/Smad and GRAP pathways.

@en

prefLabel

Ruboxistaurin attenuates diabe ...... TGF-β1/Smad and GRAP pathways.

@en

P1476

Ruboxistaurin attenuates diabe ...... TGF-β1/Smad and GRAP pathways.

@en

P2093

Asma S Al-Onazi

http://www.w3.org/2001/XMLSchema#string

Coralie Poizat

http://www.w3.org/2001/XMLSchema#string

Hala A Attia

http://www.w3.org/2001/XMLSchema#string

Maha A Al-Amin

http://www.w3.org/2001/XMLSchema#string

Nawal M Al-Rasheed

http://www.w3.org/2001/XMLSchema#string

Nouf M Al-Rasheed

http://www.w3.org/2001/XMLSchema#string

Raeesa M Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling.

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.

Essential role of Smad3 in angiotensin II-induced vascular fibrosis

Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy.

Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.

Diabetic nephropathy-pathophysiology and management.

Growth factors and the development of diabetic nephropathy.

P304

219-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JPHP.12504

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26817709

http://www.w3.org/2001/XMLSchema#string

Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.

about

P2860

P2860

Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698